ArticleJMIR research protocols2024

The Efficacy of Bepotastine Besilate Compared With Hydroxyzine Pamoate for Preventing Infusion Reactions to the First Dose of Rituximab in Patients With Non-Hodgkin Lymphoma: Protocol for a Phase II, Double-Blind, Multicenter Randomized Trial.

Yumi Kitahiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.